Adrenaline rush: the role of adrenergic receptors in stimulant-induced behaviors.
Psychostimulants, such as cocaine and amphetamines, act primarily through the monoamine neurotransmitters dopamine (DA), norepinephrine, and serotonin. Although stimulant addiction research has largely focused on DA, medication development efforts targeting the dopaminergic system have thus far been unsuccessful, leading to alternative strategies aimed at abating stimulant abuse. Noradrenergic compounds have shown promise in altering the behavioral effects of stimulants in rodents, nonhuman primates, and humans. In this review, we discuss the contribution of each adrenergic receptor (AR) subtype (α1, α2, and β) to five stimulant-induced behaviors relevant to addiction: locomotor activity, conditioned place preference, anxiety, discrimination, and self-administration. AR manipulation has diverse effects on these behaviors; each subtype profoundly influences outcomes in some paradigms but is inconsequential in others. The functional neuroanatomy and intracellular signaling mechanisms underlying the impact of AR activation/blockade on these behaviors remain largely unknown, presenting a new frontier for research on psychostimulant-AR interactions.
Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia.
Karl T
KT
Schmidt
David
D
Weinshenker
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001007:Anxiety / Q000175:diagnosis / Q000523:psychology; D001362:Avoidance Learning / Q000187:drug effects; D016739:Behavior, Addictive / Q000209:etiology / Q000523:psychology*; D001522:Behavior, Animal / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D003042:Cocaine / Q000494:pharmacology; D003214:Conditioning, Classical / Q000187:drug effects; D004192:Discrimination, Psychological / Q000187:drug effects; D009043:Motor Activity / Q000187:drug effects; D011941:Receptors, Adrenergic / Q000502:physiology*; D018340:Receptors, Adrenergic, alpha-1 / Q000502:physiology; D018341:Receptors, Adrenergic, alpha-2 / Q000502:physiology; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D012646:Self Administration; D015398:Signal Transduction
D000697:Central Nervous System Stimulants; D011941:Receptors, Adrenergic; D018340:Receptors, Adrenergic, alpha-1; D018341:Receptors, Adrenergic, alpha-2; D011943:Receptors, Adrenergic, beta; D000661:Amphetamine; D003042:Cocaine